YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2015

YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network

Résumé

Specific overexpression in cancer cells and evidence of oncogenic functions make Survivin an attractive target in cancer therapy. The small molecule compound YM155 has been described as the first "Survivin suppressant" but molecular mechanisms involved in its biological activity and its clinical potential remain obscure. We herein show that YM155 exerts single agent toxicity on primary breast cancer cells grown in an ex vivo assay preserving tumor microenvironment. In vitro assays indicate that YM155 more efficiently triggers cell death in breast cancer cells (including these with stem-cell like properties) than in non tumorigenic mammary cells. YM155-induced cell death is critically dependent on autophagy and NF-kB but independent of p53 and it coïncides with DNA damage and a DNA damage response in p53-proficient cells. Our results point out a crosstalk between NF-kB and autophagy controlling YM155-induced death in breast cancer cells and argue for the potential use of YM155 as a genotoxic agent in breast cancer therapy.

Domaines

Cancer
Fichier principal
Vignette du fichier
VequaudOncotarget2015.pdf (3.46 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-01817979 , version 1 (18-06-2018)

Identifiants

Citer

Eloïse Véquaud, Céline Séveno, Delphine Loussouarn, Lucie Engelhart, Mario Campone, et al.. YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network. Oncotarget, 2015, 6 (15), pp.13476-86. ⟨10.18632/oncotarget.3638⟩. ⟨inserm-01817979⟩
47 Consultations
95 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More